Compare MEDP & BBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MEDP | BBY |
|---|---|---|
| Founded | 1992 | 1966 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Consumer Electronics/Video Chains |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.4B | 15.6B |
| IPO Year | 2016 | N/A |
| Metric | MEDP | BBY |
|---|---|---|
| Price | $557.87 | $73.42 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 19 |
| Target Price | ★ $465.18 | $83.94 |
| AVG Volume (30 Days) | 265.4K | ★ 4.4M |
| Earning Date | 10-22-2025 | 11-25-2025 |
| Dividend Yield | N/A | ★ 5.17% |
| EPS Growth | ★ 25.36 | N/A |
| EPS | ★ 14.32 | 3.02 |
| Revenue | $2,358,373,000.00 | ★ $41,825,000,000.00 |
| Revenue This Year | $21.48 | $1.77 |
| Revenue Next Year | $11.90 | $1.32 |
| P/E Ratio | $38.96 | ★ $24.31 |
| Revenue Growth | ★ 13.88 | N/A |
| 52 Week Low | $250.05 | $54.99 |
| 52 Week High | $626.26 | $91.68 |
| Indicator | MEDP | BBY |
|---|---|---|
| Relative Strength Index (RSI) | 43.68 | 41.53 |
| Support Level | $530.96 | $71.80 |
| Resistance Level | $569.00 | $74.71 |
| Average True Range (ATR) | 16.60 | 2.48 |
| MACD | -4.63 | -0.19 |
| Stochastic Oscillator | 28.24 | 13.61 |
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
With over $41 billion in consolidated 2024 sales, Best Buy is the largest pure-play consumer electronics retailer in the US, boasting roughly 8% share of the North American market and around 33% share of offline sales in the region, per our calculations, CTA, and Euromonitor data. The firm generates the bulk of its sales in-store, with mobile phones and tablets, computers, and appliances representing its three largest categories. Recent investments in e-commerce fulfillment, accelerated by the covid pandemic, have seen the US e-commerce channel roughly double from prepandemic levels, with management estimating that it will represent a mid-30% proportion of sales moving forward.